Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?

  • At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV prevention, and recent positive estimate revisions.